Mylan takeover/merger by Teva

Started by ninjaroll, April 21, 2015, 01:30:59 PM

Previous topic - Next topic
Reply Print
Go Down Pages1
User actions

ninjaroll

April 21, 2015, 01:30:59 PM Last Edit: April 21, 2015, 02:19:32 PM by ninjaroll
http://www.wsj.com/articles/teva-offers-to-buy-mylan-for-82-a-share-1429620984

The part we care about.  Not that I truly understand the implication of Teva developing a generic or the merger of pharmaceuticals in general.

QuoteFor Teva and Mylan in recent years, sales of brand-name products have helped cushion the blows. Teva's revenue and profit have been boosted by a brand-name multiple-sclerosis drug called Copaxone, while Mylan has benefited from the branded EpiPen emergency treatment for allergic reactions.

But each company is facing competition for the key moneymakers. Just last week, Novartis AG and partner Momenta Pharmaceuticals Inc. won U.S. regulatory approval to sell a generic version of Teva's Copaxone. Meantime, Teva is among the companies trying to develop a generic EpiPen.

Reply Print
Go Up Pages1
User actions

Quick Reply

Warning: this topic has not been posted in for at least 365 days.
Unless you're sure you want to reply, please consider starting a new topic.

Name:
Email:
Verification:
Please leave this box empty:
Type the letters shown in the picture
Listen to the letters / Request another image

Type the letters shown in the picture:
Spell the answer to 6 + 7 =:
Three blonde, blue-eyed siblings are named Suzy, Jack and Bill.  What color hair does the sister have?:
Shortcuts: ALT+S post or ALT+P preview